Bupropion · more major-labeled pairs than Brexpiprazole
SPL labels Bupropion + Brexpiprazole as minor; Bupropion 32 / Brexpiprazole 9 in that band.
Mechanism on file: Brexpiprazole does not change how the liver enzymes break down bupropion in the body.
FDA SPL severity: Minor
Bupropion + Brexpiprazole · SPL mechanism field
Brexpiprazole does not change how the liver enzymes break down bupropion in the body.
Minor band excerpt · Bupropion with Brexpiprazole
Additionally, no dosage adjustment for substrates of CYP2D6 (e.g., dextromethorphan), CYP3A4 (e.g., lovastatin), CYP2B6 (e.g., bupropion), BCRP (e.g., rosuvastatin), or P-gp (e.g., fexofenadine) is required when administered concomitantly with REXULTI.
Bupropion · 1 major-labeled pairs (vs Brexpiprazole's 0)
- Carbamazepine minor
- Clopidogrel minor
- Clozapine minor
- Codeine minor
Brexpiprazole · 9 minor + 9 total pairs
- Dextromethorphan minor
- Fexofenadine minor
- Fluoxetine minor
- Lovastatin minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.